Korean J Vasc Endovasc Surg.
2013 Feb;29(1):1-5. 10.5758/kjves.2013.29.1.1.
Endovascular Stent Graft Treatment in Thoracic Aortic Aneurysmal Disease
- Affiliations
-
- 1Department of Thoracic and Cardiovascular Surgery, Inha University Hospital, Inha University School of Medicine, Incheon, Korea. jtkim@inha.ac.kr
- 2Department of Anesthesiology and Pain Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
- 3Department of Radiology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
- 4Department of Surgery, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
- KMID: 1430456
- DOI: http://doi.org/10.5758/kjves.2013.29.1.1
Abstract
- PURPOSE
The frequency of thoracic endovascular aortic repair (TEVAR) is increasing due to lower morbidity and mortality than that of open repair. The aim is to evaluate the results of TEVAR in patients with thoracic aortic disease.
METHODS
Twenty seven patients have undergone TEVAR from October, 2003 to November, 2012. Aortic diagnoses were 7 descending thoracic aortic aneurysms, 6 acute descending aortic dissections, 6 traumatic aortic transactions, 4 aortic arch aneurysms, 2 chronic descending aortic dissections, and 2 penetrating aortic ulcers (PAU). Multi detector computerized tomography (MDCT) aortography was done at one week, one month, six months, and one year interval.
RESULTS
Indications for TEVAR were aortic diameter of more than 5.5 cm in 9 patients, traumatic aortic transaction in 6, persistent chest pain in 4, increasing aortic diameter during follow-up period in 3, aneurysm rupture in 3, and PAU more than 2 cm in 2. Hybrid TEVAR was done in 7 patients. Primary technical success, showing complete aneurysmal exclusion, was done except in one patient (96%). There was one operation death (4%). Two patients developed perioperative stroke, but recovered without sequelae. MDCT was done during the mean of 18 months (range, 1 to 98 months) follow-up period. Small type I endoleak was found in two patients (7%), and type III endoleak was found in a patient (4%). Stent graft migration was in one patient. There was no aorta related deaths during the follow-up period.
CONCLUSION
Intermediate term result of TEVAR in patients with thoracic aortic aneurysmal disease was encouraging. It may be used as a treatment option for thoracic aortic disease.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Endovascular Repair of Thoracic Aortic Aneurysm Using a Custom-made Fenestrated Stent Graft to Preserve the Left Subclavian Artery
- Management for the Newly-Onset Aneurysmal Dilation of the Distal Aorta after an Endovascular Stent Graft Procedure for the Patient with Acute Aortic Dissection Type IIIb
- A Case of Complete Resolution of Aortic Dissection in the Descending Thoracic Aorta Treated with Endovascular Stent-Graft Implantation
- Endovascular Placement of Self-Expandable Stent-Graft for the Treatment of Aortic Aneurysms: 2 cases
- Use of Percutaneous Endovascular Stent Graft in Patients with Thoracic Aortic Aneurysm
